Cargando…
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Cancer immunotherapy has shown impressive anti-tumor activity in patients with advanced and early-stage malignant tumors, thus improving long-term survival. However, current cancer immunotherapy is limited by barriers such as low tumor specificity, poor response rate, and systemic toxicities, which...
Autores principales: | Wu, Peijie, Han, Jun, Gong, Yanju, Liu, Chao, Yu, Han, Xie, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612242/ https://www.ncbi.nlm.nih.gov/pubmed/36297426 http://dx.doi.org/10.3390/pharmaceutics14101990 |
Ejemplares similares
-
Nanoparticles mediated tumor microenvironment modulation: current advances and applications
por: Raju, Ganji Seeta Rama, et al.
Publicado: (2022) -
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
por: Yang, Muyue, et al.
Publicado: (2020) -
Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors
por: Zhang, Jiaxin, et al.
Publicado: (2023) -
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
por: Chen, Binlong, et al.
Publicado: (2017) -
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
por: Chung, Young Hun, et al.
Publicado: (2020)